AlloSource Co-Authors International Space Station Microbial Study with NASA’s Jet Propulsion Laboratory

Centennial, Colo. — January 16, 2018 — AlloSource, one of the nation’s largest providers of cartilage, bone, skin, soft-tissue and cellular allografts, and NASA’s Jet Propulsion Laboratory (JPL) co-authored a scientific publication titled “Detection of antimicrobial resistance genes associated with the International Space Station environmental surfaces” that was published today in Nature’s Scientific Reports. Manned space flights have always been accompanied by the human microbiome, which travels with the astronauts through the duration of the missions and remains on the International Space Station (ISS). Previous studies on the ISS have acknowledged and identified many of the microbes capable of surviving…

AlloSource Launches Placental Donation Program

Centennial, Colo. — December 20, 2017 — AlloSource, one of the nation’s largest providers of cartilage, bone, skin, soft-tissue and cellular allografts that advance patient healing, today announced the launch of the AlloSource Placental Donation Program. This initiative provides the opportunity for women undergoing scheduled caesarean sections to collaborate with AlloSource and their doctor to facilitate the donation of placental tissue following delivery. AlloSource will work directly with physicians, hospitals, and expectant mothers who are interested in donating their placental tissue following an elective C-section. The first hospital AlloSource is partnering with on the initiative is Lutheran Medical Center in…

AlloSource Announces Raime Leeby Muhle As Chief Financial Officer

Centennial, Colo. — December 14, 2017 — AlloSource, one of the nation’s largest providers of cartilage, bone, skin, soft-tissue and cellular allografts for use in surgical procedures and wound care to advance patient healing, today announced the appointment of Raime Leeby Muhle as Chief Financial Officer. With over 18 years of experience, her background spans from emerging high growth businesses to large and mature organizations. She has worked in a variety of industries including technology, distribution, manufacturing, and telecommunications. Leeby Muhle’s expertise in complex environments, as well as working cross-functionally, will help her lead the accounting, financial, and information technology…

American Heart Association Recognizes AlloSource For Workplace Health Achievements

Centennial, Colo. — December 5, 2017 — AlloSource, one of the nation’s largest providers of cartilage, bone, skin, soft-tissue and cellular allografts for use in surgical procedures and wound care to advance patient healing, today announced it received recognition from the American Heart Association for promoting a workplace culture of health and well-being. The American Heart Association’s Workplace Health Achievement Index scores companies of all sizes on 55 best practices in seven categories: leadership, engagement, programs, policies and environment, partnerships, communications, and reporting outcomes. AlloSource received Silver-level recognition for its health and wellness efforts. “Our role in healthcare gives us…

AlloSource Announces Bob Lay As Chief Operating Officer

Centennial, Colo. — November 7, 2017 — AlloSource, one of the nation’s largest providers of cartilage, bone, skin, soft-tissue and cellular allografts for use in surgical procedures and wound care to advance patient healing, today announced the appointment of Bob Lay as Chief Operating Officer. With over 20 years of experience in both finance and operations, Bob has a broad-based understanding of how each department within an organization impacts another. He has an extensive background working with businesses and medical device companies to conduct operational audits, improve processes and systems, and balance the needs of many departments to drive company…

AlloSource To Highlight AlloFuse Select CM Cellular AlloGraft Matrix At North American Spine Society Annual Meeting

Centennial, Colo. — October 24, 2017 — AlloSource, one of the nation’s largest providers of cellular, cartilage, bone, skin and soft-tissue allografts to advance patient healing in surgical procedures, will highlight AlloFuse® Select CM at the North American Spine Society Annual Meeting (NASS). AlloFuse Select CM combines osteoconductive, osteoinductive, and osteogenic properties to support the initiation and nurturing of bone growth, leading to consistent spinal fusion outcomes and delivering the benefits of autograft bone without the potential drawbacks. The product engages the body’s natural healing power and can be used in a variety of spinal, neurologic, and orthopedic procedures. “AlloFuse…

AlloSource President And CEO Thomas Cycyota Receives American Association Of Tissue Banks Award

Centennial, Colo. — October 10, 2017 — AlloSource, one of the nation’s largest providers of cartilage, bone, skin, soft-tissue and cellular allografts for use in surgical procedures and wound care to advance patient healing, today announced that its President and Chief Executive Officer, Thomas Cycyota, received the Jeanne C. Mowe Distinguished Service Award from the American Association of Tissue Banks (AATB). The annual Jeanne C. Mowe Distinguished Service Award recognizes an individual who has made a significant contribution in tissue banking or transplantation, whether in research, education, or laboratory improvement, or who has served the Association or the field of…

AlloSource And Integra LifeSciences Announce Anchor Gifts To Phoenix Society For Burn Survivors’ Never Alone Campaign

Centennial, Colo. and Plainsboro, N.J. — October 5, 2017 — AlloSource, one of the nation’s largest providers of cellular and tissue allografts, and Integra LifeSciences, a leading global medical technology company, today announced anchor gift donations to the Phoenix Society for Burn Survivors’ Never Alone Campaign. The campaign is dedicated to raising money for strategic initiatives that will enable the Phoenix Society to provide a community of support, as well as resources and tools, for burn survivors and their families. The Never Alone Campaign supports burn survivors around the world by providing access to the Phoenix Society’s programs, networks and…

AlloSource Announces Milestone In Production Of Bioengineered Blood Vessels For Humacyte’s Vascular Access Phase III Clinical Trial

Centennial, Colo. – September 12, 2017 — AlloSource, one of the nation’s largest providers of cartilage, bone, skin, soft-tissue and cellular allografts for use in surgical procedures to advance patient healing, today announced a major milestone in its partnership with Humacyte. AlloSource completed production of investigational bioengineered blood vessels for Humacyte’s Phase III clinical trial. This Phase III clinical trial is investigating the potential of Humacyte’s HUMACYL® blood vessels to improve vascular access for hemodialysis patients with end-stage renal disease. The clinical trial compares the efficacy of Humacyte’s bioengineered human-tissue vessels to the current standard of synthetic vessels manufactured from…

Philadelphia Hand To Shoulder Center Of Thomas Jefferson University Announces Prospective Study On AlloWrap In The Hand And Wrist

Philadelphia, Pa. — August 8, 2017 — Researchers at the Philadelphia Hand to Shoulder Center (PHSC) of Thomas Jefferson University (TJU) today announced the initiation of a prospective, randomized trial for the treatment of tendon adhesions of the hand and wrist using AlloSource’s AlloWrap® DS, a human amniotic membrane, in conjunction with tenolysis. The study, titled A Prospective Randomized Trial Comparing Use of AlloWrap® DS Surgical Barrier with Tenolysis versus Tenolysis Alone for Treatment of Tendon Adhesions of the Hand and Wrist, aims to identify the ideal method for treating tendon adhesions in the hand and wrist. The study will…